Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration

British Journal of Clinical Pharmacology

Volumn 72, Issue 1, 2011, Pages 143-152

  Gavaza, Paul ^a   Brown, Carolyn M ^b   Lawson, Kenneth A ^b   Rascati, Karen L ^b   Wilson, James P ^b   Steinhardt, Mary ^b  

^a Appalachian College of Pharmacy   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

ADR reporting; Adverse drug events; Attitudes; Patient and drug safety; Pharmacovigilance

Indexed keywords

ADULT; ADVERSE DRUG REACTION; ARTICLE; CONTROLLED STUDY; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH BEHAVIOR; HEALTH SERVICE; HUMAN; INCIDENT REPORT; MALE; PATIENT SAFETY; PHARMACIST ATTITUDE; PRIORITY JOURNAL; UNITED STATES; WORK EXPERIENCE;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; DRUG TOXICITY; EDUCATION, PHARMACY, CONTINUING; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PHARMACOVIGILANCE; QUESTIONNAIRES; TEXAS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 79958696382     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2011.03944.x     Document Type: Article

References (64)

1. Meadows M. Why drugs get pulled off the market. FDA Consumer Magazine 2002 January-February.
2. Lawton R, Parker D. Barriers to incident reporting in a healthcare system. Qual Saf Health Care 2002; 11: 15-8.
3. Cullen DJ, Bates DW, Small SD, Cooper JB, Nemeskal AR, Leape LL. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 1995; 21: 541-8.
4. Barach P, Smith BJ. Reporting and preventing medical mishaps: lessons from non-medical near miss reporting system. Br Med J 2000; 320: 759-63.
5. Scott H, Rosenbaum S, Waters W, Colt A, Andrews L, Juergens J, Faich G. Rhode Island physicians' recognition and reporting of adverse drug reactions. R I Med J 1987; 70: 311-6.
6. Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. JAMA 1999; 281: 824-9.
7. Cosentino M, Leoni O, Banfi F, Lecchini S, Frigo G. Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district. Pharmacol Res 1997; 35: 85-8.
8. van Grootheest AC. Improving pharmacovigilance and the role of the pharmacist. Groningen 2003.
9. Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf 2000; 23: 165-72.
10. Bäckström M, Mjörndal T, Dahlqvist R, Nordkvist-Olsson T. Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol 2000; 56: 729-32.
11. Biriell C, Edwards RI. Reasons for reporting adverse drug reactions-Some thoughts based on an international review. Pharmacoepidemiol Drug Saf 1997; 6: 21-6.
12. Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29: 385-96.
13. Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, Hernandez-Diaz S, Lasheras B. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish Region. Drug Saf 2007; 30: 1073-82.
14. van Grootheest AC, Mes K, de Jong-van den Berg LTW. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract 2002; 10: 267-72.
15. Bawazir SA. Attitude of community pharmacists in Saudi Arabia towards adverse drug reaction reporting. Saudi Pharm J 2006; 14: 75-83.
16. Bercher D. Attitudes of Paramedics to Home Hazard Inspections: Applying the Theory of Planned Behavior [Dissertation]. Little Rock, AR: University of Arkansas at Little Rock, 2008.
17. Shoham S, Gonen A. Intentions of hospital nurses to work with computers: based on the theory of planned behavior. Comput Inform Nurs 2008; 26: 106-16.
18. Nwokeji ED. Examining the Attitudes and Beliefs of Family Physicians toward the Use of Controlled-Release Opioids for the Treatement of Chronic Non-Malignant Pain [Dissertation]. Austin, TX: The University of Texas at Austin, 2007.
19. Ko N, Feng M, Chiu D, Wu M, Feng J, Pan S. Applying theory of planned behavior to predict nurses' intention and volunteering to care for SARS patients in Southern Taiwan. Kaohsiung J Med Sci 2004; 20: 389-98.
20. Meyer L. Applying the theory of planned behavior: nursing students' intention to seek clinical experiences using the essential clinical behavior database. J Nurs Educ 2002; 41: 107-16.
21. O'Boyle CA, Henly SJ, Larson E. Understanding adherence to hand hygiene recommendations: the theory of planned behavior. Am J Infect Control 2001; 29: 352-60.
22. Walker AE, Grimshaw JM, Armstrong EM. Salient beliefs and intentions to prescribe antibiotics for patients with a sore throat. Br J Health Psychol 2001; 6: 347-60.
23. Levin PF. Test of the Fishbein and Ajzen models as predictors of health care workers' glove use. Res Nurs Health 1999; 22: 295-307.
24. Millstein SG. Utility of the theories of reasoned action and planned behavior for predicting physician behavior: a prospective analysis. Health Psychol 1996; 15: 398-402.
25. Mashburn JH, Brown CM, Shepherd MD, Wilson JP, Barner JC, Marxwell JC. Using the Theory of Planned Behavior to Predict Texas Community Pharmacists' Willingness to Provide Sterile Syringes to Known Or Suspected Intravenous Drug Users [Dissertation]. Austin, TX: The University of Texas at Austin, 2003.
26. Herbert KE, Urmie JM, Newland BA, Farris KB. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Res Social Adm Pharm 2006; 2: 299-314.
27. Walker AE, Watson M, Grimshaw JM, Bond C. Applying the theory of planned behaviour to pharmacists' beliefs and intentions about the treatment of vaginal candidiasis with non-prescription medicines. Fam Pract 2004; 21: 670-6.
28. Pradel FG, Obeidat NA, Tsoukleris MG. Factors affecting pharmacists' pediatric asthma counseling. J Am Pharm Assoc (Wash DC) 2007; 47: 737-46.
29. Saengcharoen W, Chongsuvivatwong V, Lerkiatbundit S, Wongpoowarak P. Factors influencing dispensing of antibiotics for upper respiratory infections among Southern Thai community pharmacists. J Clin Pharm Ther 2008; 33: 123-9.
30. Godin G, Kok G. The theory of planned behavior: a review of its applications to health-related behaviors. Am J Health Promot 1996; 11: 87-98.
31. Feng JY, Wu YWB. Nurses' intention to report child abuse in Taiwan: a test of the theory of planned behavior. Res Nurs Health 2005; 28: 337-47.
32. Coleman CL. Examining influences of pharmacists' communication with consumers about antibiotics. Health Commun 2003; 15: 79-99.
33. Ajzen I, Fishbein M. Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs, NJ: Prentice Hall, 1980.
34. Montano D, Kasprzyk D. The theory of reasoned action and the theory of planned behavior. In: Health Behavior and Health Education: Theory, Research and Practice, 3rd edn. eds Glanz K, Rimer BK, Lewis FM. San Fransisco, CA: John Wiley & Sons, 2002; 67-98.
35. Inman WHW, ed. Detection and Investigation of Adverse Drug Reactions, 3rd edn. Oxford: Oxford University Press, 1985.
36. Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm World Sci 2009; 31: 183-7.
37. Ashcroft DM, Morecroft C, Parker D, Noyce PR. Likelihood of reporting adverse events in community pharmacy: an experimental study. Qual Saf Health Care 2006; 15: 48-51.
38. Bateman DN, Sanders GL, Rawlins MD. Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmacol 1992; 34: 421-6.
39. Institute of Medicine Report. Patient Safety: Achieving A New Standard of Care. Washington, DC: The National Academy Press, 2004.
40. Vincent C, Davy C, Esmail A, Neale G, Elstein M, Cozens JF, Walshe K. Learning from litigation. The role of claims analysis in patient safety. J Eval Clin Pract 2006; 12: 665-74.
41. Kaufman MB, Stoukides CA, Campbell NA. Physicians' liability for adverse drug reactions. South Med J 1994; 87: 780-4.
42. Inman WHW, ed. Assessment of Drug Safety Problems, 3rd edn. Hamilton, ON: McMaster University Library Press, 1978.
43. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 2009; 32: 19-31.
44. Hasford J, Goettler M, Munter KH, Müller-Oerlinghausen B. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol 2002; 55: 945-50.
45. Herdeiro MT, Figueiras A, Polonia J, Gestal-Otero JJ. Influence of pharmacists' attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2006; 29: 331-40.
46. Belton KJ, The European Pharmacovigilance Research Group. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur J Clin Pharmacol 1997; 52: 423-7.
47. Granas AG, Buajordet M, Stenberg-Nilsen H, Harg P, Horn AM. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf 2007; 16: 429-34.
48. Committee on Identifying and Preventing Medication Errors, Aspden P, Wolcott JA, Bootman JL, Cronenwett LR. Preventing Medication Errors. Institute of Medicine of the National Academies. Washington, DC: The National Academies Press, 2007.
49. Taras-Zasowski KM, Einarson TR. Review of Canadian pharmacist involvement in adverse drug reaction reporting. Can J Hosp Pharm 1989; 42: 105-8, 33.
50. Figueiras A, Tato F, Fontainas J, Gestal-Otero JJ. Influence of physicians' attitudes on reporting adverse drug events: a case-control study. Med Care 1999; 37: 809-14.
51. Eland IA, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BH. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 1999; 48: 623-7.
52. Herdeiro MT, Figueiras A, Polonia J, Gestal-Otero JJ. Physicians' attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2005; 28: 825-33.
53. Calvert RT. Clinical pharmacy - a hospital perspective. Br J Clin Pharmacol 1999; 47: 231-8.
54. van Grootheest AC, de Jong-van den Berg LTW. The role of hospital and community pharmacists in pharmacovigilance. Res Social Adm Pharm 2005; 1: 126-33.
55. Rawlins MD. Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994. J R Coll Physicians Lond 1995; 29: 41-9.
56. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J (Clin Res Ed) 2004; 329: 15-9.
57. Dormann H, Muth-Selbach U, Krebs S, Criegee-Rieck M, Tegeder I, Schneider HT, Hahn EG, Levy M, Brune K, Geisslinger G. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf 2000; 22: 161-8.
58. Emerson A, Martin RM, Tomlin M, Mann RD. Prospective cohort study of adverse events monitored by hospital pharmacists. Hospital Adverse Event Monitoring Study (HAEMS) Group. Pharmacoepidemiol Drug Saf 2001; 10: 95-103.
59. Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother 1995; 29: 365-9.
60. Kelley MA, Tucci JM. Bridging the quality chasm. Br Med J (Clin Res Ed) 2001; 323: 61-2.
61. McGettigan P, Golden J, Conroy RM, Arthur N, Feely J. Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol 1997; 44: 98-100.
62. Adams AS, Soumerai SB, Lomas J, Ross-Degnan D. Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care 1999; 11: 187-92.
63. Harrell GD, Bennett PD. An evaluation of the expectancy value model of attitude measurement for physician prescribing behavior. J Mark Res 1974; 11: 269-78.
64. Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol 2001; 51: 81-6.